Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression

dc.contributor.authorAstobiza, Ianire
dc.contributor.authorCapó Serra, Catalina
dc.contributor.authorViera, Cristina
dc.contributor.authorRodriguez, Javier
dc.contributor.authorCarnicero, Patricia
dc.contributor.authorJuliá, Miguel
dc.contributor.authorMartinez, Ainara
dc.contributor.authorPérez López, Carmen
dc.contributor.authorSubijana, María
dc.contributor.authorOrtiz Sanz, Carolina
dc.contributor.authorGarcia Longarte, Saioa
dc.contributor.authorMendizabal, Isabel
dc.contributor.authorKay, Emily J.
dc.contributor.authorRiera Domingo, Carla
dc.contributor.authorRivis, Silvia
dc.contributor.authorCarlevaris, Onintza
dc.contributor.authorEgia Mendikute, Leire
dc.contributor.authorCascais, Sara
dc.contributor.authorMartín Martín, Natalia
dc.contributor.authorFernández Ruiz, Sonia
dc.contributor.authorTorrano, Veronica
dc.contributor.authorCrespo, Jana R.
dc.contributor.authorPujana Vaquerizo, Mikel
dc.contributor.authorEspinet, Elisa
dc.contributor.authorTrumpp, Andreas
dc.contributor.authorEiro, Noemi
dc.contributor.authorVizoso, Francisco J.
dc.contributor.authorVivancos, Ana
dc.contributor.authorSeoane, Joan
dc.contributor.authorGonzalo, David
dc.contributor.authorRey, Sofía
dc.contributor.authorSantos Martín, Aida
dc.contributor.authorUgalde Olano, Aitziber
dc.contributor.authorManini, Claudia
dc.contributor.authorLópez, Jose I.
dc.contributor.authorCabrera, Diana
dc.contributor.authorVan Liempd, Sebastian M.
dc.contributor.authorFalcon Perez, Juan M.
dc.contributor.authorGomis Cabré, Roger
dc.contributor.authorPalazón, Asís
dc.date.accessioned2026-07-08T06:20:01Z
dc.date.available2026-07-08T06:20:01Z
dc.date.issued2026-06-16
dc.date.updated2026-07-07T13:58:20Z
dc.format.extent20 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina6793169
dc.identifier.issnAstobiza, Ianire; Capó-Serra, Catalina; Viera, Cristina; Rodríguez, Javier; Carnicero, Patricia; Juliá, Miguel; Martinez, Ainara; Pérez-López, Carmen; (2026). Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression. Nature Communications, (), -. DOI: 10.1038/s41467-026-73002-6
dc.identifier.issn2041-1723
dc.identifier.pmid42303618
dc.identifier.urihttps://hdl.handle.net/2445/230538
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.isformatofhttps://doi.org/10.1038/s41467-026-73002-6
dc.relation.ispartofNature Communications, 2026, vol. 17
dc.relation.uriReproducció del document publicat a: https://doi.org/10.1038/s41467-026-73002-6
dc.rightscc by-nc-nd (c) Astobiza, Ianire et al., 2026
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationProteïnes supressores de tumors
dc.subject.classificationFibroblasts
dc.subject.otherTumor suppressor protein
dc.subject.otherFibroblasts
dc.titleFibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
NatCommun_Astobiza et al_2026.pdf
Mida:
5.91 MB
Format:
Adobe Portable Document Format